Prestige Consumer Healthcare Inc (PBH)

Prestige Consumer Healthcare Inc. is a U.S.-listed common equity on the NYSE in the healthcare sector. Through its subsidiaries, the company develops, manufactures, markets, distributes, and sells over-the-counter health and personal care products across North America, Australia, and other international markets. Its portfolio includes branded products used for pain relief, diaper rash care, throat and mouth discomfort, eye care, wart removal, ear wax removal, dental hygiene, motion sickness, laxative and digestive relief, cough drops, yeast infection treatment, lice and parasite treatment, feminine care, dry eye relief, nasal saline products, and oral rehydration. Sales are made through mass merchandisers, drug and food stores, dollar and convenience outlets, club channels, and e-commerce. The company was founded in 1996, is based in Tarrytown, New York, and adopted its current name in August 2018.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-PBH
$69.82
41.1% Upside
Undervalued
$66.80
35.0% Upside
Undervalued
Great
0.0%
August 6, 2026
12.4x
1.3x
2.2x
2.388 B
3.343 B
30.4%
98.6%
8.9
129.5%
Valuation • Fair Value

Prestige Consumer Healthcare Inc (NYSE-PBH) Fair Value by Valuation Model

Compare the primary fair value estimate for Prestige Consumer Healthcare Inc (NYSE-PBH) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$69.82

Estimated upside of 41.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$81.04

Discounted cash flow valuation reference.

Ben Graham Formula Value

$44.57

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$51.56

Earnings power value estimate.

Comps Fair Value

$61.64

Comparable-company valuation reference.

Analyst Price Target

$66.80

Analysts imply upside of 35.0%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Prestige Consumer Healthcare Inc (NYSE-PBH) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Prestige Consumer Healthcare Inc (NYSE-PBH)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.089 B

Current operating scale indicator.

Revenue Forecast

1.268 B

Forward revenue estimate.

EBITDA

340.7 M

Current operating profitability reference.

EBITDA Forecast

416.1 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Prestige Consumer Healthcare Inc (NYSE-PBH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Prestige Consumer Healthcare Inc (NYSE-PBH)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.51

No elevated caution signal from this screen.

Altman Z-Score

8.9

Relatively strong balance-sheet zone.

FCF / Net Income

129.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Prestige Consumer Healthcare Inc (NYSE-PBH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Prestige Consumer Healthcare Inc (NYSE-PBH)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 6, 2026

Days to Earnings

16

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Prestige Consumer Healthcare Inc (NYSE-PBH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Prestige Consumer Healthcare Inc (NYSE-PBH) Stock Forecast & Technical Outlook

Review Prestige Consumer Healthcare Inc (NYSE-PBH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Prestige Consumer Healthcare Inc (NYSE-PBH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Prestige Consumer Healthcare Inc (NYSE-PBH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Prestige Consumer Healthcare Inc (NYSE-PBH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Prestige Consumer Healthcare Inc (NYSE-PBH) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Prestige Consumer Healthcare Inc (NYSE-PBH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Prestige Consumer Healthcare Inc (NYSE-PBH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Prestige Consumer Healthcare Inc (NYSE-PBH) has a Strong Buy consensus, with 5 buy, 2 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 2
Sell 0
FAQ Fast Investor Answers

Prestige Consumer Healthcare Inc (NYSE-PBH) Stock FAQ

Quick answers about Prestige Consumer Healthcare Inc (NYSE-PBH) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$69.82
Estimated upside 41.1%
Valuation Rating
Undervalued
Estimated upside of 41.1%
Analyst Target
$66.80
Implied upside 35.0%
Financial Health
Great
Current financial-health read

The current fair value estimate for Prestige Consumer Healthcare Inc (NYSE-PBH) is $69.82. This implies an estimated upside of 41.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 41.1% versus the current market price.

The available analyst price target for Prestige Consumer Healthcare Inc (NYSE-PBH) is $66.80. The analyst target implies estimated upside of 35.0%.

The current financial health read for Prestige Consumer Healthcare Inc (NYSE-PBH) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Prestige Consumer Healthcare Inc (NYSE-PBH) is August 6, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Prestige Consumer Healthcare Inc (NYSE-PBH) is 12.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Prestige Consumer Healthcare Inc is 2.388 B.

The current enterprise value listed for Prestige Consumer Healthcare Inc is 3.343 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Prestige Consumer Healthcare Inc is NYSE-PBH, and the stock is listed on NYSE.

Prestige Consumer Healthcare Inc (NYSE-PBH) is listed on NYSE.

The current debt-to-total-capital ratio listed for Prestige Consumer Healthcare Inc is 30.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Prestige Consumer Healthcare Inc is 98.6%. Free float helps investors understand how much of the share base is available for public trading.